Open AccessThe MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73
Author(s) -
Peirce
Publication year - 2009
Publication title -
international journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.405
H-Index - 122
ISSN - 1019-6439
DOI - 10.3892/ijo_00000267
Subject(s) - gene knockdown , doxorubicin , e2f1 , cancer research , mdm2 , neuroblastoma , apoptosis , oncogene , downregulation and upregulation , cell cycle , biology , puma , cell culture , chemotherapy , medicine , biochemistry , gene , genetics